Literature DB >> 12574553

Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes.

Susan P Laing1, Anthony J Swerdlow, Lucy M Carpenter, Stefan D Slater, Andrew C Burden, Johannes L Botha, Andrew D Morris, Norman R Waugh, Wendy Gatling, Edwin A M Gale, Christopher C Patterson, Zongkai Qiao, Harry Keen.   

Abstract

BACKGROUND AND
PURPOSE: Disease of the cardiovascular system is the main cause of long-term complications and mortality in patients with type I (insulin-dependent) and type II (non-insulin-dependent) diabetes. Cerebrovascular mortality rates have been shown to be raised in patients with type II diabetes but have not previously been reported by age and sex in patients with type I diabetes.
METHODS: A cohort of 23 751 patients with insulin-treated diabetes, diagnosed under the age of 30 years from throughout the United Kingdom, was identified during 1972 to 1993 and followed up for mortality until the end of December 2000. Age- and sex-specific mortality rates and standardized mortality ratios (SMRs) were calculated.
RESULTS: There were 1437 deaths during the follow-up, 80 due to cerebrovascular disease. Overall, the cerebrovascular mortality rates in the cohort were higher than the corresponding rates in the general population, and the SMRs were 3.1 (95% CI, 2.2 to 4.3) for men and 4.4 (95% CI, 3.1 to 6.0) for women. When stratified by age, the SMRs were highest in the 20- to 39-year age group. After subdivision of cause of death into hemorrhagic and nonhemorrhagic origins, there remained a significant increase in mortality from stroke of nonhemorrhagic origin.
CONCLUSIONS: Analyses of mortality from this cohort, essentially one of patients with type I diabetes, has shown for the first time that cerebrovascular mortality is raised at all ages in these patients. Type I diabetes is at least as great a risk factor for cerebrovascular mortality as type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574553     DOI: 10.1161/01.str.0000053843.03997.35

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

Review 1.  Cerebrovascular complications of diabetes: focus on stroke.

Authors:  Adviye Ergul; Aisha Kelly-Cobbs; Maha Abdalla; Susan C Fagan
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895

2.  Predictors of and survival after incident stroke in type 1 diabetes.

Authors:  Aaron M Secrest; Catherine T Prince; Tina Costacou; Rachel G Miller; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2012-04-25       Impact factor: 3.291

3.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

4.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

5.  Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia.

Authors:  Peter Reismann; Christoph Lichy; Gottfried Rudofsky; Per M Humpert; Just Genius; Tuan-Dong Si; Christof Dörfer; Armin J Grau; Andreas Hamann; Werner Hacke; Peter P Nawroth; Angelika Bierhaus
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 6.  The use of metformin in type 1 diabetes: a systematic review of efficacy.

Authors:  S Vella; L Buetow; P Royle; S Livingstone; H M Colhoun; J R Petrie
Journal:  Diabetologia       Date:  2010-01-08       Impact factor: 10.122

Review 7.  Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.

Authors:  Daniel J Moore; Justin M Gregory; Yaa A Kumah-Crystal; Jill H Simmons
Journal:  Vasc Health Risk Manag       Date:  2009-11-23

8.  Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Authors:  Tina Costacou; Aaron M Secrest; Robert E Ferrell; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2014-07-03       Impact factor: 3.291

9.  Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study.

Authors:  Simone H de Castro; Hugo C Castro-Faria-Neto; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2005-11-10

Review 10.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.